Vibrato clot removal for pulmonary embolism safety study
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had symptoms of a pulmonary embolism for 14 days or less.
- A CT scan shows a clot in one of the main lung arteries and your heart's right side is enlarged.
- Your blood pressure is stable (systolic at least 90 mmHg) and your heart rate is under 130 beats per minute.
- You haven't used clot-busting drugs in the last 30 days.
- You don't have severe lung disease, recent stroke, or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
This trial tests a new system to remove blood clots from the lungs in people with acute pulmonary embolism (a sudden blockage in a lung artery). It may help those who are stable enough for a catheter-based procedure but still have significant strain on the heart.
This study looks at patients having a procedure to remove blood clots from the lungs. It checks how stable their heart and breathing are during the procedure to help doctors know what to expect.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.